References
Levi M, Ten Cate H. Disseminated intravascular coagulation. N Engl J Med. 1999;341:586–92.
Okajima K, Sakamoto Y, Uchiba M. Heterogeneity in the incidence and clinical manifestations of disseminated intravascular coagulation: a study of 204 cases. Am J Hematol. 2000;65:215–22.
Sallah S, Wan JY, Nguyen NP, Hanrahan LR, Sigounas G. Disseminated intravascular coagulation in solid tumors: clinical and pathologic study. Thromb Haemost. 2001;86:828–33.
Chao Y, Teng HC, Hung HC, et al. Successful initial treatment with weekly etoposide, epirubicin, cisplatin, 5-fluorouracil and leucovorin chemotherapy in advanced gastric cancer patients with disseminated intravascular coagulation. Jpn J Clin Oncol. 2000;30:122–5.
Takashima A, Shirao K, Hirashima Y, et al. Sequential chemotherapy with methotrexate and 5-fluorouracil for chemotherapy-naive advanced gastric cancer with disseminated intravascular coagulation at initial diagnosis. J Cancer Res Clin Oncol. 2010;136:243–8.
Huang TC, Yeh KH, Cheng AL, Hsu CH. Weekly 24-hour infusional 5-fluorouracil as initial treatment for advanced gastric cancer with acute disseminated intravascular coagulation. Anticancer Res. 2008;28:1293–7.
Hironaka S, Ueda S, Yasui H, et al. Randomized, open-label, phase III study comparing irinotecan with paclitaxel in patients with advanced gastric cancer without severe peritoneal metastasis after failure of prior combination chemotherapy using fluoropyrimidine plus platinum: WJOG 4007 trial. J Clin Oncol. 2013;31:4438–44.
Chu E, Vincent T, Jr DV. Physicians’ cancer chemotherapy drug manual. Massachusetts: Jones and Bartlett; 2012.
Field KM, Michael M. Part II: liver function in oncology: towards safer chemotherapy use. Lancet Oncol. 2008;9:1181–90.
Kimura A, Kawasaki H, Wajima N, et al. A case of rapidly fatal gastric cancer with disseminated carcinomatosis of the bone marrow. Gan To Kagaku Ryoho. 2013;40:2322–4 (in Japanese).
Maekawa T. Diagnostic criteria for disseminated intravascular coagulation. Annual report of the Research Committee of Blood Coagulation Disorder, the Ministry of Health and Welfare of Japan. 1980; 5–12 (in Japanese).
Mayumi T, Wada H, Matsushita T, et al. Current clinicians’ medical care for DIC: from the results of questionnaire at the first conference of Tokai DIC up to date. J Jpn Soc Thromb Hemost. 2007;18:619–26 (in Japanese).
Pasquini E, Gianni L, Aitini E, et al. Acute disseminated intravascular coagulation syndrome in cancer patients. Oncology. 1995;52:505–8.
Fung WP, Barr A. Fulminant disseminated intravascular coagulation in advanced gastric carcinoma. Am J Gastroenterol. 1979;71:210–2.
Rhee J, Han SW, Oh DY, et al. Clinicopathologic features and clinical outcomes of gastric cancer that initially presents with disseminated intravascular coagulation: a retrospective study. J Gastroenterol Hepatol. 2010;25:1537–42.
Hwang IG, Choi JH, Park SH, et al. Chemotherapy in advanced gastric cancer patients associated with disseminated intravascular coagulation. Cancer Res Treat. 2014;46:27–32.
Im CK, Rha SY, Jeung HC, et al. A phase II feasibility study of weekly paclitaxel in heavily pretreated advanced gastric cancer patients with poor performance status. Oncology. 2009;77:349–57.
Jen CJ, Mclntire LV. Platelet microtubules in clot structure formation and contractile force generation: investigation of a controversy. Thromb Haemost. 1986;56:23–7.
Conflict of Interest
The authors declare that they have no competing interests.
Funding
This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kawai, S., Sakamoto, Y., Takahashi, Y. et al. Efficacy and Safety of Weekly Paclitaxel Therapy for Advanced Gastric Cancer Patients with Disseminated Intravascular Coagulation. J Gastrointest Canc 46, 438–441 (2015). https://doi.org/10.1007/s12029-015-9744-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12029-015-9744-x